Universidad de Salamanca
Enfermedad injerto contra huésped crónica: factores pronósticos y nuevas opciones terapéuticas
Abstract
[EN] The classification proposed by the NIH in conjunction with other factors present at the time of diagnosis of chronic GVHD possible to establish groups of patients with different prognosis. In this regard, the reevaluation of the day + 100 after transplantation might be useful to identify patients at risk EICHc develop severe forms. Finally, in patients with forms EICHc mild or moderate symptoms can be controlled from disease using topical drugs or no effect systemic immunosuppression. The main objectives are twofold. On the one hand, the analysis of prognostic factors in the context of chronic graft versus host disease: a. A retrospective evaluation of classification and NIH identification of other prognostic factors. b. Retrospective analysis of day +100 screening factor predictor of EICHc Furthermore, prospective and retrospective study of new strategies therapeutic in EICHc a. Treatment of gastrointestinal EICHc beclomethasone b. Role of vitamin D in controlling EICHc
Author and committee
dc:creator, dc:contributor.*- Author
-
- Da Silva, Fernando Da Mota Veiga Mendes
Subjects
dc:subject × 7Identifiers
dc:identifier.*- Identifier
- hdl:10366/83333
- OAI identifier oai:identifier
- oai:gredos.usal.es:10366/83333